Showing results (1711-1720 of 2,001) with videos related to

Sort By:
Pageof 201
Gut|January 13, 2001
Fine mapping of the chromosome 3p susceptibility locus in inflammatory bowel diseaseJ Hampe, N J Lynch, S Daniels, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 25, 1998
Pediatric and adult lung transplantation for cystic fibrosisE N Mendeloff, C B Huddleston, G B Mallory, et al.
Pharmaceutical Research|March 1, 1994
Pharmacokinetics and pharmacodynamics of L-703,014, a potent fibrinogen receptor antagonist, after intravenous and oral administration in the dogJ S Barrett, R J Gould, J D Ellis, et al.
Circulation|July 1, 1991
Effective thrombolysis without marked plasminemia after bolus intravenous administration of vampire bat salivary plasminogen activator in rabbitsS J Gardell, D R Ramjit, I I Stabilito, et al.
Biorxiv : the Preprint Server for Biology|July 3, 2023
Lysinoalanine crosslinking is a conserved post-translational modification in the spirochete flagellar hookMichael J Lynch, Maithili Deshpande, Kurni Kyrniyati, et al.
Microbiology Resource Announcements|January 11, 2020
Metagenome-Assembled Genome Sequences of Five Strains from the Microtus ochrogaster (Prairie Vole) Fecal MicrobiomeMeghan Donovan, Michael D J Lynch, Calvin S Mackey, et al.
FEBS Letters|December 9, 1998
Neuronal expression of fractalkine in the presence and absence of inflammationW J Schwaeble, C M Stover, T J Schall, et al.
The Journal of Biological Chemistry|August 25, 2010
Cyclic AMP phosphodiesterase 4D (PDE4D) Tethers EPAC1 in a vascular endothelial cadherin (VE-Cad)-based signaling complex and controls cAMP-mediated vascular permeabilitySarah N Rampersad, Jeffrey D Ovens, Elaine Huston, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Phase I and pharmacokinetic study of gimatecan given orally once a week for 3 of 4 weeks in patients with advanced solid tumorsAndrew X Zhu, Neal Ready, Jeffrey W Clark, et al.
Seminars in Oncology|August 1, 1997
Ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer: update and preliminary survival analysisG M Strauss, T J Lynch, A D Elias, et al.
Pageof 201